392 SUPPRESSION OF PROSTATE CANCER GROWTH BY A NEUTRALIZING ANTI-TRANSFORMING GROWTH FACTOR-BETA (Tgf-Β) ANTIBODY 1D11

Qiang Zhang,Lin Chen,Brian Helfand,Norm Smith,Julie Zhu,Borko Javonovic,Yinglu Guo,Chung Lee
DOI: https://doi.org/10.1016/j.juro.2010.02.460
2010-01-01
Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research III1 Apr 2010392 SUPPRESSION OF PROSTATE CANCER GROWTH BY A NEUTRALIZING ANTI-TRANSFORMING GROWTH FACTOR-BETA (TGF-β) ANTIBODY 1D11 Qiang Zhang, Lin Chen, Brian Helfand, Norm Smith, Julie Zhu, Borko Javonovic, Yinglu Guo, and Chung Lee Qiang ZhangQiang Zhang Chicago, IL , Lin ChenLin Chen Chicago, IL , Brian HelfandBrian Helfand Chicago, IL , Norm SmithNorm Smith Chicago, IL , Julie ZhuJulie Zhu Boston, MA , Borko JavonovicBorko Javonovic Chicago, IL , Yinglu GuoYinglu Guo Beijing, People's Republic of China , and Chung LeeChung Lee Chicago, IL View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.460AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Transforming growth factor-β (TGF-β)is a potent immunosuppressant molecule. In previous studies, we showed that over-production of TGF-β by prostate cancer derived cells results in evasion of host immune surveillance and tumor progression. In this study, we explored the potential of immunotherapy for prostate cancer by a specific neutralizing anit-TGF-β antibody 1D11. METHODS We have obtained an expression vector with a triple fusion protein, containing HSV1-tk-GFP-luciferase (SFG-nTGL) from Dr.Vladimir Ponomarev of the Memorial Sloan Kettering Cancer Center. Mouse prostate cancer TRAMP-C2 cells are transfected with this reporter gene, designated as TRAMP-luciferase. This new approach will allow us to monitor tumor load in intact animals and the effects of therapy through a noninvasive bioluminescence imaging technology. The study was initiated using the approach of subcutaneous (sc) injection of TRAMP-luciferase cells (5x106 cells) into the right flank region of 30 C57BL/6 mice. Animals are randomly assigned to three groups following with intraperitoneal injection of a specific neutralizing anti-TGF-?antibody 1D11 or control antibody 13C4 respectively at the time of tumor cell injection. Group 1:1D11 (50 mg/kg every 3 days); Group 2:13C4 (50 mg/kg every 3 days), and Group 3: no treatment control. All the mice were killed after 15 time injection of antibodies. The size and weight of tumor, weight of prostate and spleen were measured. RESULTS In the group treated with 1D11 1 of 10 mice were free of tumor, and all the mice in 13C4 treatment group and control group have tumors. The average tumor weight and volume in the remaining 9 mice in 1D11 group was 5.3g and 6.85 cm2 respectively which is almost 2-5 folds less than that of animals in 13C4 treatment group (15.8mg and 12.85 mm2) and no treatment group (31.4mg and 23.39 mm2) (P<0.01). There is no significant difference on the weight of prostate and there is no significant metastasis on all the groups by the monitor of bioluminescence imaging. Interestingly, upon treatment with 1D11, the weight of spleen (101 mg) increased when compared to another two groups 76.4 mg and 80.4 mg respectively. CONCLUSIONS The data indicated that neutralization of tumor secreted TGF-?by 1D11 may induce the host immune response which could be helpful for recovery of host anti-tumor immune response inhibited by TGF-β.The inhibition of TGF-β then results in the suppression of prostate cancer growth. This study may lead to the development of effective antitumor therapeutic strategies in the near future. © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e155 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.Metrics Author Information Qiang Zhang Chicago, IL More articles by this author Lin Chen Chicago, IL More articles by this author Brian Helfand Chicago, IL More articles by this author Norm Smith Chicago, IL More articles by this author Julie Zhu Boston, MA More articles by this author Borko Javonovic Chicago, IL More articles by this author Yinglu Guo Beijing, People's Republic of China More articles by this author Chung Lee Chicago, IL More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?